September 15, 2011 - U-Systems, the leader in automated breast ultrasound, announced the first Canadian installation of the somo•v automated breast ultrasound (ABUS) system at VIP Breast Imaging in Toronto. The announcement was made at the Multimodality Detection and Diagnosis of Breast Diseases Conference being held at the Westin Harbour Castle in Toronto, September 6-9. The company also announced an agreement to partner with VIP Breast Imaging as they expand their imaging centers coast-to-coast across Canada.
”We are very excited to offer somo•v automated breast ultrasound, to our clients. The somo•v ABUS has been proven especially effective in women with dense breast tissue who have an increased risk of breast cancer.” said Tina Ureten, MD, RDMS, RDCS, founder and president of VIP Breast Imaging. “Even for women who do not have dense breast tissue, ABUS provides a safe, non-ionizing breast creening option. We are pleased to offer this service to all Canadian women who wish early screening as a personal choice.”
U-Systems was recently granted a medical device license by the Medical Devices Bureau of Health Canada to sell and market the somo•v ABUS system as an adjunct to mammography for screening asymptomatic women for breast cancer in Canada. It is the only ultrasound device approved for breast cancer screening by Health Canada. The somo•v ABUS system is also the only ultrasound device approved for breast cancer screening in the 27 European Union countries. In the United States, the somo•v ABUS system is cleared by the United States Food and Drug Administration (FDA) for adjunctive diagnostic use with mammography.
Using proprietary technology to automate the breast ultrasound imaging process, the U-Systems’ somo•v ABUS is ideally suited for the high-volume, screening environment. The somo•viewer Advanced 3-D Workstation enables fast review and archive of patient exams, optimizing breast ultrasound screening workflow.
For more information: www.u-systems.com
July 24, 2024 
